Cargando…

Epigenetic mechanisms in breast cancer therapy and resistance

The majority of breast cancers express the estrogen receptor (ERα) and agents targeting this pathway represent the main treatment modality. Endocrine therapy has proven successful in the treatment of hormone-responsive breast cancer since its early adoption in the 1940s as an ablative therapy. Unfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Martinez, Liliana, Zhang, Yusheng, Nakata, Yuichiro, Chan, Ho Lam, Morey, Lluis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979820/ https://www.ncbi.nlm.nih.gov/pubmed/33741974 http://dx.doi.org/10.1038/s41467-021-22024-3

Ejemplares similares

Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer
por: Zhang, Yusheng, et al.
Publicado: (2020)

GD2+ cancer stem cells in triple-negative breast cancer: mechanisms of resistance to breast cancer therapies
por: Nguyen, Khoa, et al.
Publicado: (2022)

Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance
por: Rytlewski, Jeff, et al.
Publicado: (2022)

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls
por: Morganti, Stefania, et al.
Publicado: (2022)

Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms
por: Chan, Ho Lam, et al.
Publicado: (2018)

Progress in targeted therapy for breast cancer
por: Ju, Jie, et al.
Publicado: (2018)

Endocrine resistant breast cancer: brain metastasis
por: Willman, Matthew, et al.
Publicado: (2022)

Epigenetic reprogramming in small cell lung cancer
por: Chen, Jingyao, et al.
Publicado: (2022)

Association of Hypertension and Breast Cancer: Antihypertensive Drugs as an Effective Adjunctive in Breast Cancer Therapy
por: Fan, Yuanyuan, et al.
Publicado: (2022)

BAP1 in cancer: epigenetic stability and genome integrity
por: Caporali, Sabrina, et al.
Publicado: (2022)

Epigenetics, Darwin, and Lamarck
por: Penny, David
Publicado: (2015)

Rare Mutations in Cancer Drug Resistance and Implications for Therapy
por: Beckman, Robert A., et al.
Publicado: (2020)

Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer
por: Abdel-Hafiz, Hany A.
Publicado: (2017)

Necessity of Epigenetic Epidemiology Studies on the Carcinogenesis of Lung Cancer in Never Smokers
por: Bae, Jong-Myon
Publicado: (2018)

The Mendelian disorders of the epigenetic machinery
por: Bjornsson, Hans Tomas
Publicado: (2015)

Transgenerational epigenetics and environmental justice
por: Rothstein, Mark A., et al.
Publicado: (2017)

Communicating science: epigenetics in the spotlight
por: Dyke, Stephanie O M, et al.
Publicado: (2020)

The genetics and epigenetics of satellite centromeres
por: Talbert, Paul B., et al.
Publicado: (2022)

An FCA-mediated epigenetic route towards thermal adaptation of autotrophic development in plants
por: Lee, Hyo-Jun, et al.
Publicado: (2017)

Editorial: Epigenetic Regulation of Stem Cell Plasticity in Tissue Regeneration and Disease
por: Chiacchiera, Fulvio, et al.
Publicado: (2020)

The role of non-genetic inheritance in evolutionary rescue: epigenetic buffering, heritable bet hedging and epigenetic traps
por: O’Dea, Rose E., et al.
Publicado: (2016)

Developmental origins of epigenetic transgenerational inheritance
por: Hanson, Mark A., et al.
Publicado: (2016)

Epigenetic regulation of kidney progenitor cells
por: Huang, Biao, et al.
Publicado: (2020)

Assessing the Epigenetic Status of Human Telomeres
por: Vaquero-Sedas, María I., et al.
Publicado: (2019)

Epigenetics in the public sphere: interdisciplinary perspectives
por: Dubois, Michel, et al.
Publicado: (2019)

Epigenetic Inheritance and Transgenerational Environmental Justice
por: Korolenko, Alexandra A., et al.
Publicado: (2023)

Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy
por: Zargar, Amin, et al.
Publicado: (2020)

Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?
por: Lazo, Pedro A.
Publicado: (2022)

Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy
por: Artzy-Randrup, Yael, et al.
Publicado: (2021)

PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy
por: Augimeri, Giuseppina, et al.
Publicado: (2021)

Cutting the root: the next generation of T cells engagers against cancer stem cells to overcome drug resistance in triple-negative breast cancer
por: Zhang, Jiali, et al.
Publicado: (2023)

Epigenetic Therapy for Breast Cancer
por: Cai, Feng-Feng, et al.
Publicado: (2011)

Guest Editorial: Epigenetics: Environmental Instructions for the Genome
por: Wade, Paul A., et al.
Publicado: (2006)

Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins
por: Silberman, Dafne M.
Publicado: (2018)

Genetic and epigenetic control of the spatial organization of the genome
por: Brickner, Jason
Publicado: (2017)

Towards a unification of the 2 meanings of “epigenetics”
por: Huang, Sui
Publicado: (2022)

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach
por: Lowe, Leroy, et al.
Publicado: (2022)

Bringing epigenetics into the diagnostics of the andrology laboratory: challenges and perspectives
por: Kläver, Ruth, et al.
Publicado: (2014)

5-Hydroxymethylcytosine: a new kid on the epigenetic block?
por: Matarese, Filomena, et al.
Publicado: (2011)

Transgenerational Epigenetic Contributions to Stress Responses: Fact or Fiction?
por: Nestler, Eric J.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t3rru06ul7ckuohk7p9efdneef